Bifrost competitors

Bhatt is a veteran of the biotechnology industry with more than 30 years of experience in pharmaceutical development and diagnostics. At Hoffman-La Roche, he developed human IL-2, gamma-Interferon and Human Growth Hormone Releasing Factor pharmaceuticals. He developed a diagnostic for sexually transmitted diseases and the key components of HPA technology, which generate more than $500 million a year in commercial diagnostic revenue for Gen-Probe. For Biocept, Dr. Bhatt developed a non-invasive diagnostic test for fetal RhD genotyping and a fetal gender-determination test from maternal blood at eight to nine weeks gestation. He invented and developed a novel device to capture and analyze circulating fetal cells and tumor cells to diagnose prenatal disorders and cancers. Dr. Bhatt has served as a member of the National Institutes of Health Grant Review Board.

Serial CEO,INT'L Crisis Mgmt/ Turnaround specialist, Exec Coach, Advisor to & Member of BODs. I help struggling companies move to the next level, reorganize, pivot, become repositioned and agile. My value includes six primary areas:1)Ameliorating crisis situations 2)Repositioning companies on the edge of failure 3)Re-igniting stagnated or unprofitable companies in need of growth to sustainable profit and exit 4)Integrating acquisitions 5)Building highly effective and agile teams 6)Providing leadership and strategic coaching. During my 30 years as a \'C\' level executive (20 plus as CEO;10 as CFO/Controller), I have helped some 29 institutionally funded (VC & PE) Portfolio companies return to profitability, accelerate revenue growth, and achieve Board desired exits, salvaging more than 19 companies from near death and complete loss of invested funds. ** Location, Situation and Duration agnostic** Years spent successfully correcting under achieving situations, provide coaching/mentoring, strategy planning, agility management training. I raise capital, and build high functioning management teams that maximize opportunity for venture level returns. I stand ready to serve the concerns of the investment community and those struggling with: start-ups, High Growth, early stage thru exit.--I get you across the white water of Crisis situations -- taking companies to the next level (high-growth) Specialties: Successful Turnaround Specialist -- Crisis Management --Team building, Managing INT'L Org's, M&A, IPO's: Software,Hardware, Manufacturing, Medical Devices, Engineering, Construction, Venture Capital. • Short, intermediate and long term interim Mgmt • Coaching, team building, agility training • Acquisition Integration or divestitures • Revenue Growth and Profit Improvement • Capital formation/ refinancing • Strategic Planning and Change Leadership • Value-added Product Road-maps • Multi-site Global Operations Management • Rapid growth • Risk/Crisis Management

Jacqueline Corbelli is a Founder, Chairman, Chief Executive Officer at BrightLine and is based in Brightline. She works or has worked at CNBC.

As an accomplished executive with over 25 years of operations, management, and consulting expertise, Kelly specializes in introducing new transformational strategies and innovative business solutions that evolve operating models and spawn new profitable revenue sources. - Executive Advisor and Management Consultant- Global Enterprise & Sales Management (US&C, EMEA, APAC, and LATAM)- Commercial Industry Expertise (Healthcare & Life Sciences, Travel & Transportation, and Banking)- Financial / P&L Responsibility Exceeding $1 billion- Strategic Account and Client Management- Industry Verticalization and Solution Ideation - Alliance Management and Collaborative Offering DevelopmentOver his career, Kelly has held executive leadership positions at GlaxoSmithKline, EDS, Unisys, Tech Mahindra, and IMS Health.